Navigation Links
Global Cystic Fibrosis Therapeutics Market 2016-2026
Date:1/6/2017

LONDON, Jan. 5, 2017 /PRNewswire/ -- Report Details

The latest report from business intelligence provider visiongain offers comprehensive analysis of the global cystic fibrosis market. Visiongain expects the global cystic fibrosis market to grow at a CAGR of 16.7% from 2016 to 2021. The global cystic fibrosis market is estimated to reach $7.7bn by 2021.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this 191-page report you will receive 113 tables, charts and graphs – all unavailable elsewhere.

The 191 page report provides clear detailed insight into the global cystic fibrosis market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

- Global Cystic Fibrosis market forecasts from 2016-2026

- Cystic Fibrosis submarket forecasts from 2016-2026 covering:
- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
- Protein Transcription Modulators
- Pancreatic Enzyme Products (PEP)
- Other therapies

- Individual drug revenue forecasts from 2016-2026 by pharmacological classes:

- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators:
- Orkambi
- Kalydeco
- VX-661 + ivacaftor
- Second corrector/VX-661/ivacaftor

- Protein Transcription Modulators
- Pulmozyme
- QR-010
- Translarna

- Pancreatic Enzyme Products (PEP)
- Ceron

- Other therapies
- Cayston
- TOBI

- Revenue forecasts from 2016-2026 and discussion of relevant trends and developments in the leading national cystic fibrosis market

- Analysis of the key factors driving growth in the global, regional and country level of the Cystic Fibrosis Market from 2016-2026

- Patent and clinical trials information of the marketed and pipeline products for cystic fibrosis

- The dynamic of pricing, patient share and market share of the leading cystic fibrosis drugs in the US and Europe

- Discussion on selected leading companies marketing and developing cystic fibrosis drugs:
- Vertex Pharmaceuticals
- Roche
- AbbVie
- Gilead Sciences
- Novartis

Visiongain's study is intended for anyone requiring commercial analyses for the Cystic Fibrosis Market and leading companies. You find data, trends and predictions.

Download the full report: https://www.reportbuyer.com/product/4594353/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-cystic-fibrosis-therapeutics-market-2016-2026-300386902.html


'/>"/>
SOURCE ReportBuyer
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Anesthesia Disposables - Medical Equipment & Supplies
2. Eisai Acquires All Global Development And Marketing Rights For Chronic Weight Management Treatment Lorcaserin HCI
3. Global Ulcerative Colitis Partnering 2010-2016
4. Research and Markets - Global Peripheral Vascular Diagnostic Systems Market (2016-2020) - Product, Application & End User - Key Vendors are ArjoHuntleigh, Viasonix & Opto Circuits
5. Medical Devices: Technologies and Global Markets
6. Global Hospital Beds (Powered and Manual) - Medical Equipment & Supplies
7. Global Cholesterol Testing - Clinical Diagnostics
8. Global Home Medical Equipment Technologies Market Analysis & Trends - Industry Forecast to 2025
9. Global Point of Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022
10. Global Audiological Devices - Medical Equipment & Supplies
11. Diabetes Injection Pens Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
(Date:5/11/2017)...  Thornhill Research Inc. ( Toronto, Ontario, ... USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by the U.S. ... (CCC) ( Ottawa, Ontario, Canada ) ... anesthesia to patients requiring emergency medical procedures in ... Corps have been a longtime partner with Thornhill ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... the Peace Agreements being discussed by President Donald Trump and the rest of the ... to speed up peace talks in the continuous battle between Israel and Palestine. The ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “When the ... Lead Home” is the creation of published author Laura Weigel Douglas, an avid reader ... cat in a house that sometimes feels like Green Hills Adventure Camp. She couldn’t ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Cactus Jack: Against All Odds”: ... many others. “Cactus Jack: Against All Odds” is the creation of published author, ... Hubbard is married to Jack Carlisle’s third child Jane. Walter. Walter and Jane ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... Dr. Alan ... surgery in New York City. He is known for his distinguished expertise and ... vascular surgery, Dr. Benvenisty holds sub-specialty training in treating renovascular disease and aortic ...
(Date:5/24/2017)... ... ... Dr. Manju R. Kejriwal, a leading Ohio dentist, is now welcoming new ... Dr. Kejriwal understands the emotional and financial toll traditional orthodontics can take on patients’ ... longer need to feel the esthetic effects of wires and brackets when they can ...
Breaking Medicine News(10 mins):